CIK 0001446847
- Accelerated filer
- Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043404176
- Phone
- +1 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- 4 Open-market sale Director sold 20,000 shares at $11.67 ($233,400)
- 4 Grant or award Chief Executive Officer acquired 248,869 shares (grant or award)
- 4 Grant or award SVP, Chief Operating Officer acquired 90,498 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 47,013 shares (grant or award)
- 4 Grant or award CMO,SVP,Head-Res&Drug acquired 81,448 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 67,873 shares (grant or award)
- 4 Open-market sale Principal Accounting Officer sold 2,238 shares at $10.77 ($24,103)
- 4 Open-market sale Chief Executive Officer sold 48,424 shares at $10.77 ($521,526)
- 4 Open-market sale CMO,SVP,Head-Res&Drug sold 17,607 shares at $10.77 ($189,627)
- 4 Open-market sale SVP, Chief Operating Officer sold 28,962 shares at $10.77 ($311,921)
- 4 Grant or award CMO,SVP,Head-Res&Drug acquired 29,326 shares (grant or award)
- 4 Grant or award SVP, Chief Operating Officer acquired 36,174 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 60,290 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 46,327 shares at $11.41 ($528,591)
- 4 Open-market sale SVP, Chief Operating Officer sold 27,000 shares at $11.28 ($304,560)
- 4 Grant or award Director acquired 1,211 shares (grant or award)
- 4 Grant or award Director acquired 1,431 shares (grant or award)
- 4 Grant or award Director acquired 1,541 shares (grant or award)
- 4 Open-market sale Director sold 10,000 shares at $11.02 ($110,200)
- 4 Grant or award SVP, Chief Financial Officer acquired 85,000 shares (grant or award)
Page 10 of 41 · 806 filings